Lipocine LPCN
NASDAQ LPCN
$2.05 -0.02 (-0.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lipocine (LPCN) Other Accumulated Expenses (2017 - 2022)

Updated

Lipocine (LPCN) reported Other Accumulated Expenses of $1 million for Q1 2022, unchanged from the prior quarter.

Analysis

Lipocine (LPCN) Other Accumulated Expenses (2017 - 2022) Analysis & Trends

Dating back to Q4 2017, Lipocine's Other Accumulated Expenses record includes 6 quarters.

  • Other Accumulated Expenses has a four-year compound annual growth rate of -30.4% (FY2017 to FY2021).
  • By year, Other Accumulated Expenses came in at $4.25 million in FY2017.
  • Five-year quarterly Other Accumulated Expenses spans a low of $1 million in Q3 2021 and a high of $4.25 million in Q1 2018.
  • Per Business Quant data, the three quarters before Q1 2022 came in at $1 million (Q4 2021), $1 million (Q3 2021) and $2.5 million (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lipocine 11.11 Mn -56.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.00 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 1.00 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2018 4.25 Mn
Dec 31, 2017 4.25 Mn
API Access

Lipocine Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LPCN&period=max&api_key=YOUR_API_KEY